Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 121 clinical trials
A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease

This trial is a randomized, open label, two-arm, parallel-group, non-used comparator, single center trial to evaluate the efficacy of dapagliflozin in subjects with Nonalcoholic fatty liver disease. This is a principal investigator initiate study. This study is supported by Liver Disease Prevention & Treatment Research Foundation. Dapagliflozin will be provided …

  • 0 views
  • 20 Apr, 2022
  • 1 location
Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

calorie ketogenic diet (VLCKD) on gut permeability and liver steatosis. The first objective is to examine the influence of obesity on the prevalence and severity of impaired intestinal permeability

  • 0 views
  • 04 Oct, 2022
  • 1 location
The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes

The purpose of this study is to examine whether a low carbohydrate diet decreases hepatic lipid content and changes hepatic mitochondrial flux in humans.

Accepts healthy volunteers
  • 25 views
  • 01 Feb, 2022
  • 1 location
"LiverColor": Machine Learning in Liver Photographs

The main goal of this project is to create a machine learning model in order to quantify liver steatosis in liver donor faster, more objective and reliable than histological analysis and

  • 0 views
  • 23 Mar, 2022
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation

to perform disease severity assessment. The objective of this study is to assess the performance of a new non-invasive ultrasound-based system for the assessment of liver fibrosis and steatosis

fibrosis
liver disease
  • 0 views
  • 19 Nov, 2021
  • 1 location
Liver Cancer Prevention Randomized Control Trial

To determine the effectiveness of a behaviorally-based tailored disease management intervention in patients with fibrosis or steatosis and risk factors for cirrhosis.

fibrosis
liver disease
cancer
hbsag
fibroscan
  • 10 views
  • 22 Mar, 2022
  • 1 location
Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease

A 2 x 2 cross-over dietary intervention trial designed to investigate the effects of low glycemic index (LGI) versus high glycemic index (HGI) diet on hepatic fat accumulation and gut microbiota composition in participants with NAFLD. Participants will be allocated randomly to a 2-week either high GI (HGI) or low …

  • 0 views
  • 09 Oct, 2021
  • 1 location
Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) Study

Omega-3 has been postulated to reduce hepatic steatosis by reducing lipogenic gene expression, exerting anti- inflammation action, reducing oxidative stress and improving glycemic control.

liver disease
central obesity
fatty liver
dietary intervention
fish oil
  • 1 views
  • 21 Sep, 2021
  • 1 location
  • 80 views
  • 13 Jul, 2022
  • 7 locations
"CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.

produces a significant reduction in liver steatosis and is associated with a higher rate of weight loss compared to standard recommendations currently indicated in Primary Care.

  • 0 views
  • 14 Aug, 2021
  • 1 location